CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn’t Spared.

CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn’t Spared.
·2 min read

CureVac says its intellectual property portfolio protects multiple inventions that are considered essential to Pfizer and BioNTech's Covid-19 vaccine.